Detalhe da pesquisa
1.
LANCL1, a cell surface protein, promotes liver tumor initiation through FAM49B-Rac1 axis to suppress oxidative stress.
Hepatology
; 79(2): 323-340, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540188
2.
Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma.
Gut
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38839271
3.
Midline 1 interacting protein 1 promotes cancer metastasis through FOS-like 1-mediated matrix metalloproteinase 9 signaling in HCC.
Hepatology
; 78(5): 1368-1383, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632999
4.
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos.
Gut
; 72(7): 1370-1384, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36631249
5.
Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma.
Hepatology
; 76(1): 48-65, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767674
6.
Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma.
J Hepatol
; 77(2): 383-396, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35227773
7.
Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma.
Hepatology
; 73(1): 23-40, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32170761
8.
Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
Hepatology
; 63(2): 474-87, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26481868
9.
Proline-rich acidic protein 1 (PRAP1) is a novel interacting partner of MAD1 and has a suppressive role in mitotic checkpoint signalling in hepatocellular carcinoma.
J Pathol
; 233(1): 51-60, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24374861
10.
Sorted-Cell Sequencing on HCC Specimens Reveals EPS8L3 as a Key Player in CD24/CD13/EpCAM-Triple Positive, Stemness-Related HCC Cells.
Cell Mol Gastroenterol Hepatol
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38750898
11.
PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner.
Cell Mol Gastroenterol Hepatol
; 15(6): 1325-1350, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806581
12.
Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.
Hepatology
; 53(5): 1558-69, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21520171
13.
Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1.
Cell Biosci
; 11(1): 217, 2021 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34924003
14.
Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma.
Nat Commun
; 12(1): 3684, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140495
15.
Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma.
Liver Int
; 30(1): 65-75, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19845851
16.
Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and stemness-related subpopulations in liver cancer.
Cancer Lett
; 459: 176-185, 2019 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31195060
17.
Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer.
Oncogenesis
; 7(5): 44, 2018 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29799025
18.
Dishevelled-3 phosphorylation is governed by HIPK2/PP1Cα/ITCH axis and the non-phosphorylated form promotes cancer stemness via LGR5 in hepatocellular carcinoma.
Oncotarget
; 8(24): 39430-39442, 2017 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28455968
19.
C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
Oncotarget
; 8(14): 23507-23516, 2017 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28186991
20.
RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma.
Oncotarget
; 7(27): 41445-41459, 2016 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27213590